Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Comp Immunol Microbiol Infect Dis ; 26(5-6): 423-30, 2003 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-12818626

RESUMO

Bioterrorist attacks occupy a special place amongst the innumerable potential types of terrorist attack, with the intentional release of pox viruses being especially feared in this connection. Apart from the variola virus, the agent responsible for smallpox in humans, the monkeypox virus and numerous other animal pox viruses pose potential risks for humans and animals. This risk scenario also includes recombinations between the various pox viruses, changes in hosts and genetically engineered manipulations of pox viruses. For over 200 years, the method of choice for combatting smallpox was via vaccination with a reproductive, original vaccinia virus. Worldwide eradication of smallpox at the end of the 1970s and the discontinuation of routine smallpox vaccination in 1980 can be credited to such vaccination. Unfortunately, these vaccinations were associated with a large number of postvaccinal impairments, sometimes resulting in death (e.g. postvaccinal encephalitis). The only way to restrict such postvaccinal complications was to carry out initial vaccination within the first 2 postnatal years. Initial vaccination at a later age led to such a sharp increase in the number of vaccines with complications that vaccination had to be discouraged. The dilemma of the smallpox vaccine stocks stems from the fact that a large portion of these stocks are produced with the same vaccinia strains as before. This is irresponsible, especially as the percentage of immune-suppressed persons in the population, for whom vaccination-related complications pose an especial threat, is increasing. One solution to the dilemma of the smallpox vaccine stocks is the MVA strain. It is harmless, protects humans and animals equally well against smallpox and can be applied parenterally.


Assuntos
Bioterrorismo , Vacina Antivariólica/administração & dosagem , Varíola/prevenção & controle , Vacinação/métodos , Vírus da Varíola , Animais , Humanos , Vacina Antivariólica/efeitos adversos , Vacina Antivariólica/normas , Vacinação/efeitos adversos
2.
Pesqui. vet. bras ; 19(3/4): 91-98, jul.-dez. 1999. ilus, tab
Artigo em Inglês | LILACS | ID: lil-325114

RESUMO

The so-called primitive, innate or paraspecific immune system is the phylogenetically older part of the complex immune system. It enables the organism to immediately attack various foreign substances, infectious pathogens, toxins and transformed cells of the organism itself. "Paramunity" is defined as an optimal regulated and activated, antigen-nonspecific defence, acquired through continuous active and succesful confrontation with endogenous and exogenous noxes or by means of "paramunization" with so called "paramunity inducers". Paramunity inducers based on different pox virus species (e.g. Baypamun®, Duphapind®, Conpind) have turned out to be effective and safe when applied with human beings as well as with animals. Pox virus inducers activate phagocytosis and NK-cells in addition to regulation of various cytokines, notably interferon a and g, IL 1, 2, CSF and TNF which comprise the network of the complex paraspecific immune system. The results of experimental work as well as practical use in veterinary medicine have shown that paramunization by pox inducers goes far beyond the common understanding of so-called ,,immuno-therapy". They are "bioregulators", because they have 1. a regulatory effect on a disturbed immune system in the sense of an optimal homoeostasis, and 2. simultaneously a regulatory effect between the immune, nervous, circulatory and hormone system. Therefore, the use of paramunization by pox inducers opens a new way of prophylaxis and therapy, not only with regard to infections, but also with regard to different other indications


Assuntos
Animais , Humanos , Imunoterapia , Poxviridae , Sistema Imunitário
3.
Artigo em Espanhol | PAHO-IRIS | ID: phr3-51320

RESUMO

El virus aftoso, con sus 7 serotipos, representa un género separado de la familia de los Picornaviridae. Las diferencias más importantes de los otros virus Picorna se refieren a su isodensidad de 1,43, la tasa de sedimentación de 146 S y su marcada inestabilidad al medio ácido. Desde el punto de vista estructural y funcional, en el virus aftoso se pueden distinguir 4 unidades: 1. el virión (146 S), 2. el cápside vacío (75 S), 3. los capsómeros (12 S) y 4. el ARN viral de cadena simple (37 S). Se discuten las características morfológica, físico-químicas y biológicas de las 4 unidades estructurales y se explican resultados de importancia en cuanto a su aplicación práctica, especialmente con respecto a la patogenicidad, el diagnóstico y la inmunoprofilaxis.


Assuntos
Febre Aftosa , Aphthovirus , Diagnóstico , Vacinas , Anticorpos , Antígenos , Patogenesia Homeopática , Sorologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...